Ionis Pharmaceuticals, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
Ionis Pharmaceuticals, Inc. (IONS) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 10.26 million shares for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2019-03-01
- Ionis Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2018-12-31 was 10.26M shares.
- Ionis Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2015-06-30 was 3.68M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month |
|---|---|---|
| 2018-12-31 | 10.26M shares 10-K · filed 2019-03-01 | |
| 2015-06-30 | 3.68M shares 10-K · filed 2017-03-01 | 0.00 shares 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |